HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000119 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 12, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
180,000
Total Value
$8,645,911.38
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 9, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 9, 2026 | Sale | 13,304 | $107.22 | $1,426,481.49 | 774,476 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 9, 2026 | Sale | 6,596 | $107.82 | $711,187.32 | 767,880 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 9, 2026 | Sale | 100 | $108.67 | $10,867.00 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 10, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 10, 2026 | Sale | 14,588 | $107.01 | $1,561,091.06 | 773,192 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 10, 2026 | Sale | 5,412 | $107.58 | $582,228.37 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 11, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 11, 2026 | Sale | 15,492 | $107.15 | $1,660,029.77 | 772,288 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 11, 2026 | Sale | 4,508 | $107.55 | $484,826.38 | 767,780 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Sep 9, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 121,552 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Sep 10, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 101,552 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Sep 11, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 81,552 | Direct | โ | View Details |